KR
Kalaiselvi Rajarathinam
About Kalaiselvi Rajarathinam
Data last updated:
Kalaiselvi Rajarathinam is a Director at Stemcell Transplantation Assisted Reproduction Research Private Limited (since 2016) and Director at Kims Ivf Fertility Centre Private Limited (since 2013). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹8.88 Cr; the largest is Stemcell Transplantation Assisted Reproduction Research Private Limited at ₹7.68 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Mar 2016 | 2016 | ₹7.68 Cr (FY 2023) | Active | |
| Director | 25 Nov 2013 | 2013 | ₹1.20 Cr (FY 2023) | Active |
Board colleagues of Kalaiselvi Rajarathinam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Govindasamy Rajarathinam | 06366467 | Stemcell Transplantation Assisted Reproduction Research Private Limited , Kims Ivf Fertility Centre Private Limited | Whole-Time Director |
| Selvaraj Krishnammal | 06727208 | Kims Ivf Fertility Centre Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalaiselvi Rajarathinam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalaiselvi Rajarathinam
Kalaiselvi Rajarathinam currently holds 2 directorships: Stemcell Transplantation Assisted Reproduction Research Private Limited (Director, since 02 Mar 2016, revenue ₹7.68 Cr (FY 2023)); Kims Ivf Fertility Centre Private Limited (Director, since 25 Nov 2013, revenue ₹1.20 Cr (FY 2023)).
Kalaiselvi Rajarathinam was first appointed on 25 Nov 2013 as Director at Kims Ivf Fertility Centre Private Limited. The most recent appointment on record is 02 Mar 2016 at Stemcell Transplantation Assisted Reproduction Research Private Limited.
The 2 current companies of Kalaiselvi Rajarathinam that report revenue have a combined latest revenue of ₹8.88 Cr: Stemcell Transplantation Assisted Reproduction Research Private Limited ₹7.68 Cr (FY 2023); Kims Ivf Fertility Centre Private Limited ₹1.20 Cr (FY 2023).
The current boards of Kalaiselvi Rajarathinam's companies include Govindasamy Rajarathinam (Stemcell Transplantation Assisted Reproduction Research Private Limited), Selvaraj Krishnammal (Kims Ivf Fertility Centre Private Limited).